Table of Content

1 Myotonic Dystrophy Drug Market Overview
1.1 Myotonic Dystrophy Drug Product Scope
1.2 Myotonic Dystrophy Drug Segment by Type
1.2.1 Global Myotonic Dystrophy Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Sodium Channel Blocker
1.2.3 Tricyclic Antidepressant
1.2.4 Other
1.3 Myotonic Dystrophy Drug Segment by Distribution Channel
1.3.1 Global Myotonic Dystrophy Drug Sales Comparison by Distribution Channel (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Myotonic Dystrophy Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Myotonic Dystrophy Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Myotonic Dystrophy Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Myotonic Dystrophy Drug Price Trends (2016-2027)

2 Myotonic Dystrophy Drug Estimates and Forecasts by Region
2.1 Global Myotonic Dystrophy Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Myotonic Dystrophy Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Myotonic Dystrophy Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Myotonic Dystrophy Drug Revenue Market Share by Region (2016-2021)
2.3 Global Myotonic Dystrophy Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Myotonic Dystrophy Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Myotonic Dystrophy Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Myotonic Dystrophy Drug Estimates and Projections (2016-2027)
2.4.2 Europe Myotonic Dystrophy Drug Estimates and Projections (2016-2027)
2.4.3 China Myotonic Dystrophy Drug Estimates and Projections (2016-2027)
2.4.4 Japan Myotonic Dystrophy Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Myotonic Dystrophy Drug Estimates and Projections (2016-2027)
2.4.6 India Myotonic Dystrophy Drug Estimates and Projections (2016-2027)
3 Global Myotonic Dystrophy Drug Competition Landscape by Players
3.1 Global Top Myotonic Dystrophy Drug Players by Sales (2016-2021)
3.2 Global Top Myotonic Dystrophy Drug Players by Revenue (2016-2021)
3.3 Global Myotonic Dystrophy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Myotonic Dystrophy Drug as of 2020)
3.4 Global Myotonic Dystrophy Drug Average Price by Company (2016-2021)
3.5 Manufacturers Myotonic Dystrophy Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Myotonic Dystrophy Drug Market Size by Type
4.1 Global Myotonic Dystrophy Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Myotonic Dystrophy Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Myotonic Dystrophy Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Myotonic Dystrophy Drug Price by Type (2016-2021)
4.2 Global Myotonic Dystrophy Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Myotonic Dystrophy Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Myotonic Dystrophy Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Myotonic Dystrophy Drug Price Forecast by Type (2022-2027)
5 Global Myotonic Dystrophy Drug Market Size by Distribution Channel
5.1 Global Myotonic Dystrophy Drug Historic Market Review by Distribution Channel (2016-2021)
5.1.1 Global Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2016-2021)
5.1.2 Global Myotonic Dystrophy Drug Revenue Market Share by Distribution Channel (2016-2021)
5.1.3 Global Myotonic Dystrophy Drug Price by Distribution Channel (2016-2021)
5.2 Global Myotonic Dystrophy Drug Market Estimates and Forecasts by Distribution Channel (2022-2027)
5.2.1 Global Myotonic Dystrophy Drug Sales Forecast by Distribution Channel (2022-2027)
5.2.2 Global Myotonic Dystrophy Drug Revenue Forecast by Distribution Channel (2022-2027)
5.2.3 Global Myotonic Dystrophy Drug Price Forecast by Distribution Channel (2022-2027)

6 North America Myotonic Dystrophy Drug Market Facts & Figures
6.1 North America Myotonic Dystrophy Drug Sales by Company
6.1.1 North America Myotonic Dystrophy Drug Sales by Company (2016-2021)
6.1.2 North America Myotonic Dystrophy Drug Revenue by Company (2016-2021)
6.2 North America Myotonic Dystrophy Drug Sales Breakdown by Type
6.2.1 North America Myotonic Dystrophy Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Myotonic Dystrophy Drug Sales Breakdown by Type (2022-2027)
6.3 North America Myotonic Dystrophy Drug Sales Breakdown by Distribution Channel
6.3.1 North America Myotonic Dystrophy Drug Sales Breakdown by Distribution Channel (2016-2021)
6.3.2 North America Myotonic Dystrophy Drug Sales Breakdown by Distribution Channel (2022-2027)

7 Europe Myotonic Dystrophy Drug Market Facts & Figures
7.1 Europe Myotonic Dystrophy Drug Sales by Company
7.1.1 Europe Myotonic Dystrophy Drug Sales by Company (2016-2021)
7.1.2 Europe Myotonic Dystrophy Drug Revenue by Company (2016-2021)
7.2 Europe Myotonic Dystrophy Drug Sales Breakdown by Type
7.2.1 Europe Myotonic Dystrophy Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Myotonic Dystrophy Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Myotonic Dystrophy Drug Sales Breakdown by Distribution Channel
7.3.1 Europe 134 Sales Breakdown by Distribution Channel (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Distribution Channel (2022-2027)

8 China Myotonic Dystrophy Drug Market Facts & Figures
8.1 China Myotonic Dystrophy Drug Sales by Company
8.1.1 China Myotonic Dystrophy Drug Sales by Company (2016-2021)
8.1.2 China Myotonic Dystrophy Drug Revenue by Company (2016-2021)
8.2 China Myotonic Dystrophy Drug Sales Breakdown by Type
8.2.1 China Myotonic Dystrophy Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Myotonic Dystrophy Drug Sales Breakdown by Type (2022-2027)
8.3 China Myotonic Dystrophy Drug Sales Breakdown by Distribution Channel
8.3.1 China 245 Sales Breakdown by Distribution Channel (2016-2021)
8.3.2 China 245 Sales Breakdown by Distribution Channel (2022-2027)

9 Japan Myotonic Dystrophy Drug Market Facts & Figures
9.1 Japan Myotonic Dystrophy Drug Sales by Company
9.1.1 Japan Myotonic Dystrophy Drug Sales by Company (2016-2021)
9.1.2 Japan Myotonic Dystrophy Drug Revenue by Company (2016-2021)
9.2 Japan Myotonic Dystrophy Drug Sales Breakdown by Type
9.2.1 Japan Myotonic Dystrophy Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Myotonic Dystrophy Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Myotonic Dystrophy Drug Sales Breakdown by Distribution Channel
9.3.1 Japan Jan. Sales Breakdown by Distribution Channel (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Distribution Channel (2022-2027)

10 Southeast Asia Myotonic Dystrophy Drug Market Facts & Figures
10.1 Southeast Asia Myotonic Dystrophy Drug Sales by Company
10.1.1 Southeast Asia Myotonic Dystrophy Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Myotonic Dystrophy Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Myotonic Dystrophy Drug Sales Breakdown by Type
10.2.1 Southeast Asia Myotonic Dystrophy Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Myotonic Dystrophy Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Myotonic Dystrophy Drug Sales Breakdown by Distribution Channel
10.3.1 Southeast Asia K Unit Sales Breakdown by Distribution Channel (2016-2021)
10.3.2 Southeast Asia K Unit Sales Breakdown by Distribution Channel (2022-2027)

11 India Myotonic Dystrophy Drug Market Facts & Figures
11.1 India Myotonic Dystrophy Drug Sales by Company
11.1.1 India Myotonic Dystrophy Drug Sales by Company (2016-2021)
11.1.2 India Myotonic Dystrophy Drug Revenue by Company (2016-2021)
11.2 India Myotonic Dystrophy Drug Sales Breakdown by Type
11.2.1 India Myotonic Dystrophy Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Myotonic Dystrophy Drug Sales Breakdown by Type (2022-2027)
11.3 India Myotonic Dystrophy Drug Sales Breakdown by Distribution Channel
11.3.1 India Myotonic Dystrophy Drug Sales Breakdown by Distribution Channel (2016-2021)
11.3.2 India Myotonic Dystrophy Drug Sales Breakdown by Distribution Channel (2022-2027)

12 Company Profiles and Key Figures in Myotonic Dystrophy Drug Business
12.1 Lupin
12.1.1 Lupin Corporation Information
12.1.2 Lupin Business Overview
12.1.3 Lupin Myotonic Dystrophy Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Lupin Myotonic Dystrophy Drug Products Offered
12.1.5 Lupin Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Business Overview
12.2.3 Teva Myotonic Dystrophy Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Myotonic Dystrophy Drug Products Offered
12.2.5 Teva Recent Development
12.3 ANI Pharmaceuticals
12.3.1 ANI Pharmaceuticals Corporation Information
12.3.2 ANI Pharmaceuticals Business Overview
12.3.3 ANI Pharmaceuticals Myotonic Dystrophy Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 ANI Pharmaceuticals Myotonic Dystrophy Drug Products Offered
12.3.5 ANI Pharmaceuticals Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Business Overview
12.4.3 Mylan Myotonic Dystrophy Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan Myotonic Dystrophy Drug Products Offered
12.4.5 Mylan Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Business Overview
12.5.3 Novartis Myotonic Dystrophy Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Novartis Myotonic Dystrophy Drug Products Offered
12.5.5 Novartis Recent Development
12.6 Sun Pharma
12.6.1 Sun Pharma Corporation Information
12.6.2 Sun Pharma Business Overview
12.6.3 Sun Pharma Myotonic Dystrophy Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sun Pharma Myotonic Dystrophy Drug Products Offered
12.6.5 Sun Pharma Recent Development
12.7 Mallinckrodt
12.7.1 Mallinckrodt Corporation Information
12.7.2 Mallinckrodt Business Overview
12.7.3 Mallinckrodt Myotonic Dystrophy Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Mallinckrodt Myotonic Dystrophy Drug Products Offered
12.7.5 Mallinckrodt Recent Development
...

13 Myotonic Dystrophy Drug Manufacturing Cost Analysis
13.1 Myotonic Dystrophy Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Myotonic Dystrophy Drug
13.4 Myotonic Dystrophy Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Myotonic Dystrophy Drug Distributors List
14.3 Myotonic Dystrophy Drug Customers

15 Market Dynamics
15.1 Myotonic Dystrophy Drug Market Trends
15.2 Myotonic Dystrophy Drug Drivers
15.3 Myotonic Dystrophy Drug Market Challenges
15.4 Myotonic Dystrophy Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Myotonic Dystrophy Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Myotonic Dystrophy Drug Sales ((US$ Million)) Comparison by Distribution Channel (2016 & 2021 & 2027)
Table 3. Global Myotonic Dystrophy Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Myotonic Dystrophy Drug Sales (K Unit) by Region (2016-2021)
Table 5. Global Myotonic Dystrophy Drug Sales Market Share by Region (2016-2021)
Table 6. Global Myotonic Dystrophy Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Myotonic Dystrophy Drug Revenue Share by Region (2016-2021)
Table 8. Global Myotonic Dystrophy Drug Sales (K Unit) Forecast by Region (2022-2027)
Table 9. Global Myotonic Dystrophy Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Myotonic Dystrophy Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Myotonic Dystrophy Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Myotonic Dystrophy Drug Sales (K Unit) of Key Companies (2016-2021)
Table 13. Global Myotonic Dystrophy Drug Sales Share by Company (2016-2021)
Table 14. Global Myotonic Dystrophy Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Myotonic Dystrophy Drug Revenue Share by Company (2016-2021)
Table 16. Global Myotonic Dystrophy Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myotonic Dystrophy Drug as of 2020)
Table 17. Global Myotonic Dystrophy Drug Average Price (USD$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Myotonic Dystrophy Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Myotonic Dystrophy Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Myotonic Dystrophy Drug Sales (K Unit) by Type (2016-2021)
Table 22. Global Myotonic Dystrophy Drug Sales Share by Type (2016-2021)
Table 23. Global Myotonic Dystrophy Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Myotonic Dystrophy Drug Price (USD$/Unit) by Type (2016-2021)
Table 25. Global Myotonic Dystrophy Drug Sales Share by Type (2022-2027)
Table 26. Global Myotonic Dystrophy Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Myotonic Dystrophy Drug Revenue Share by Type (2022-2027)
Table 28. Global Myotonic Dystrophy Drug Price (USD$/Unit) by Type (2022-2027)
Table 29. Global Myotonic Dystrophy Drug Sales (K Unit) by Distribution Channel (2016-2021)
Table 30. Global Myotonic Dystrophy Drug Sales Share by Distribution Channel (2016-2021)
Table 31. Global Myotonic Dystrophy Drug Revenue (US$ Million) Market Share by Distribution Channel (2016-2021)
Table 32. Global Myotonic Dystrophy Drug Price (USD$/Unit) by Distribution Channel (2016-2021)
Table 33. Global Myotonic Dystrophy Drug Sales (K Unit) by Distribution Channel (2022-2027)
Table 34. Global Myotonic Dystrophy Drug Sales Share by Distribution Channel (2022-2027)
Table 35. Global Myotonic Dystrophy Drug Revenue (US$ Million) Market Share by Distribution Channel (2022-2027)
Table 36. Global Myotonic Dystrophy Drug Revenue Share by Distribution Channel (2022-2027)
Table 37. Global Myotonic Dystrophy Drug Price (USD$/Unit) by Distribution Channel (2022-2027)
Table 38. North America Myotonic Dystrophy Drug Sales (K Unit) by Company (2016-2021)
Table 39. North America Myotonic Dystrophy Drug Sales Market Share by Company (2016-2021)
Table 40. North America Myotonic Dystrophy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Myotonic Dystrophy Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Myotonic Dystrophy Drug Sales by Type (2016-2021) & (K Unit)
Table 43. North America Myotonic Dystrophy Drug Sales Market Share by Type (2016-2021)
Table 44. North America Myotonic Dystrophy Drug Sales by Type (2022-2027) & (K Unit)
Table 45. North America Myotonic Dystrophy Drug Sales Market Share by Type (2022-2027)
Table 46. North America Myotonic Dystrophy Drug Sales by Distribution Channel (2016-2021) & (K Unit)
Table 47. North America Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2016-2021)
Table 48. North America Myotonic Dystrophy Drug Sales by Distribution Channel (2022-2027) & (K Unit)
Table 49. North America Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2022-2027)
Table 50. Europe Myotonic Dystrophy Drug Sales (K Unit) by Company (2016-2021)
Table 51. Europe Myotonic Dystrophy Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Myotonic Dystrophy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Myotonic Dystrophy Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Myotonic Dystrophy Drug Sales by Type (2016-2021) & (K Unit)
Table 55. Europe Myotonic Dystrophy Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Myotonic Dystrophy Drug Sales by Type (2022-2027) & (K Unit)
Table 57. Europe Myotonic Dystrophy Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Myotonic Dystrophy Drug Sales by Distribution Channel (2016-2021) & (K Unit)
Table 59. Europe Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2016-2021)
Table 60. Europe Myotonic Dystrophy Drug Sales by Distribution Channel (2022-2027) & (K Unit)
Table 61. Europe Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2022-2027)
Table 62. China Myotonic Dystrophy Drug Sales (K Unit) by Company (2016-2021)
Table 63. China Myotonic Dystrophy Drug Sales Market Share by Company (2016-2021)
Table 64. China Myotonic Dystrophy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Myotonic Dystrophy Drug Revenue Market Share by Company (2016-2021)
Table 66. China Myotonic Dystrophy Drug Sales by Type (2016-2021) & (K Unit)
Table 67. China Myotonic Dystrophy Drug Sales Market Share by Type (2016-2021)
Table 68. China Myotonic Dystrophy Drug Sales by Type (2022-2027) & (K Unit)
Table 69. China Myotonic Dystrophy Drug Sales Market Share by Type (2022-2027)
Table 70. China Myotonic Dystrophy Drug Sales by Distribution Channel (2016-2021) & (K Unit)
Table 71. China Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2016-2021)
Table 72. China Myotonic Dystrophy Drug Sales by Distribution Channel (2022-2027) & (K Unit)
Table 73. China Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2022-2027)
Table 74. Japan Myotonic Dystrophy Drug Sales (K Unit) by Company (2016-2021)
Table 75. Japan Myotonic Dystrophy Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Myotonic Dystrophy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Myotonic Dystrophy Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Myotonic Dystrophy Drug Sales by Type (2016-2021) & (K Unit)
Table 79. Japan Myotonic Dystrophy Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Myotonic Dystrophy Drug Sales by Type (2022-2027) & (K Unit)
Table 81. Japan Myotonic Dystrophy Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Myotonic Dystrophy Drug Sales by Distribution Channel (2016-2021) & (K Unit)
Table 83. Japan Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2016-2021)
Table 84. Japan Myotonic Dystrophy Drug Sales by Distribution Channel (2022-2027) & (K Unit)
Table 85. Japan Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2022-2027)
Table 86. Southeast Asia Myotonic Dystrophy Drug Sales (K Unit) by Company (2016-2021)
Table 87. Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Myotonic Dystrophy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Myotonic Dystrophy Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Myotonic Dystrophy Drug Sales by Type (2016-2021) & (K Unit)
Table 91. Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Myotonic Dystrophy Drug Sales by Type (2022-2027) & (K Unit)
Table 93. Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Myotonic Dystrophy Drug Sales by Distribution Channel (2016-2021) & (K Unit)
Table 95. Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2016-2021)
Table 96. Southeast Asia Myotonic Dystrophy Drug Sales by Distribution Channel (2022-2027) & (K Unit)
Table 97. Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2022-2027)
Table 98. India Myotonic Dystrophy Drug Sales (K Unit) by Company (2016-2021)
Table 99. India Myotonic Dystrophy Drug Sales Market Share by Company (2016-2021)
Table 100. India Myotonic Dystrophy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Myotonic Dystrophy Drug Revenue Market Share by Company (2016-2021)
Table 102. India Myotonic Dystrophy Drug Sales by Type (2016-2021) & (K Unit)
Table 103. India Myotonic Dystrophy Drug Sales Market Share by Type (2016-2021)
Table 104. India Myotonic Dystrophy Drug Sales by Type (2022-2027) & (K Unit)
Table 105. India Myotonic Dystrophy Drug Sales Market Share by Type (2022-2027)
Table 106. India Myotonic Dystrophy Drug Sales by Distribution Channel (2016-2021) & (K Unit)
Table 107. India Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2016-2021)
Table 108. India Myotonic Dystrophy Drug Sales by Distribution Channel (2022-2027) & (K Unit)
Table 109. India Myotonic Dystrophy Drug Sales Market Share by Distribution Channel (2022-2027)
Table 110. Lupin Corporation Information
Table 111. Lupin Description and Business Overview
Table 112. Lupin Myotonic Dystrophy Drug Sales (K Unit), Revenue (Million USD), Price (USD$/Unit) and Gross Margin (2016-2021)
Table 113. Lupin Myotonic Dystrophy Drug Product
Table 114. Lupin Recent Development
Table 115. Teva Corporation Information
Table 116. Teva Description and Business Overview
Table 117. Teva Myotonic Dystrophy Drug Sales (K Unit), Revenue (Million USD), Price (USD$/Unit) and Gross Margin (2016-2021)
Table 118. Teva Myotonic Dystrophy Drug Product
Table 119. Teva Recent Development
Table 120. ANI Pharmaceuticals Corporation Information
Table 121. ANI Pharmaceuticals Description and Business Overview
Table 122. ANI Pharmaceuticals Myotonic Dystrophy Drug Sales (K Unit), Revenue (Million USD), Price (USD$/Unit) and Gross Margin (2016-2021)
Table 123. ANI Pharmaceuticals Myotonic Dystrophy Drug Product
Table 124. ANI Pharmaceuticals Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Myotonic Dystrophy Drug Sales (K Unit), Revenue (Million USD), Price (USD$/Unit) and Gross Margin (2016-2021)
Table 128. Mylan Myotonic Dystrophy Drug Product
Table 129. Mylan Recent Development
Table 130. Novartis Corporation Information
Table 131. Novartis Description and Business Overview
Table 132. Novartis Myotonic Dystrophy Drug Sales (K Unit), Revenue (Million USD), Price (USD$/Unit) and Gross Margin (2016-2021)
Table 133. Novartis Myotonic Dystrophy Drug Product
Table 134. Novartis Recent Development
Table 135. Sun Pharma Corporation Information
Table 136. Sun Pharma Description and Business Overview
Table 137. Sun Pharma Myotonic Dystrophy Drug Sales (K Unit), Revenue (Million USD), Price (USD$/Unit) and Gross Margin (2016-2021)
Table 138. Sun Pharma Myotonic Dystrophy Drug Product
Table 139. Sun Pharma Recent Development
Table 140. Mallinckrodt Corporation Information
Table 141. Mallinckrodt Description and Business Overview
Table 142. Mallinckrodt Myotonic Dystrophy Drug Sales (K Unit), Revenue (Million USD), Price (USD$/Unit) and Gross Margin (2016-2021)
Table 143. Mallinckrodt Myotonic Dystrophy Drug Product
Table 144. Mallinckrodt Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Myotonic Dystrophy Drug Distributors List
Table 148. Myotonic Dystrophy Drug Customers List
Table 149. Myotonic Dystrophy Drug Market Trends
Table 150. Myotonic Dystrophy Drug Market Drivers
Table 151. Myotonic Dystrophy Drug Market Challenges
Table 152. Myotonic Dystrophy Drug Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Myotonic Dystrophy Drug Product Picture
Figure 2. Global Myotonic Dystrophy Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Myotonic Dystrophy Drug Sales Market Share by Distribution Channel in 2021 & 2027
Figure 6. Hospital Pharmacy Examples
Figure 7. Retail Pharmacy Examples
Figure 8. Other Examples
Figure 9. Global Myotonic Dystrophy Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Myotonic Dystrophy Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Myotonic Dystrophy Drug Sales (K Unit) Growth Rate (2016-2027)
Figure 12. Global Myotonic Dystrophy Drug Price Trends Growth Rate (2016-2027) (USD$/Unit)
Figure 13. Global Myotonic Dystrophy Drug Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Myotonic Dystrophy Drug Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Myotonic Dystrophy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Myotonic Dystrophy Drug Sales (K Unit) Growth Rate (2016-2027)
Figure 17. Europe Myotonic Dystrophy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Myotonic Dystrophy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Myotonic Dystrophy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Myotonic Dystrophy Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Myotonic Dystrophy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Myotonic Dystrophy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Myotonic Dystrophy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Myotonic Dystrophy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Myotonic Dystrophy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Myotonic Dystrophy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Myotonic Dystrophy Drug Players Market Share by Revenue in Myotonic Dystrophy Drug: 2016 & 2020
Figure 28. Myotonic Dystrophy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Myotonic Dystrophy Drug Revenue Share by Type (2016-2021)
Figure 30. Global Myotonic Dystrophy Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Myotonic Dystrophy Drug Revenue Share by Distribution Channel (2016-2021)
Figure 32. Global Myotonic Dystrophy Drug Revenue Growth Rate by Distribution Channel in 2016 & 2020
Figure 33. North America Myotonic Dystrophy Drug Sales Market Share by Type in 2020
Figure 34. North America Myotonic Dystrophy Drug Sales Market Share by Distribution Channel in 2020
Figure 35. Europe Myotonic Dystrophy Drug Sales Market Share by Type in 2020
Figure 36. Europe Myotonic Dystrophy Drug Sales Market Share by Distribution Channel in 2020
Figure 37. China Myotonic Dystrophy Drug Sales Market Share by Type in 2020
Figure 38. China Myotonic Dystrophy Drug Sales Market Share by Distribution Channel in 2020
Figure 39. Japan Myotonic Dystrophy Drug Sales Market Share by Type in 2020
Figure 40. Japan Myotonic Dystrophy Drug Sales Market Share by Distribution Channel in 2020
Figure 41. Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Type in 2020
Figure 42. Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Distribution Channel in 2020
Figure 43. India Myotonic Dystrophy Drug Sales Market Share by Type in 2020
Figure 44. India Myotonic Dystrophy Drug Sales Market Share by Distribution Channel in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Myotonic Dystrophy Drug
Figure 47. Manufacturing Process Analysis of Myotonic Dystrophy Drug
Figure 48. Myotonic Dystrophy Drug Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed